Cargando…
Delayed-type hypersensitivity in classic Kaposi sarcoma patients and controls
BACKGROUND: Immune perturbation likely affects the development of Kaposi sarcoma (KS) among people infected with the KS-associated herpesvirus (KSHV). We tested whether KSHV-seropositive individuals or cases of classic KS (cKS), which typically originates in the leg, had differing delayed-type hyper...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049575/ https://www.ncbi.nlm.nih.gov/pubmed/21245864 http://dx.doi.org/10.1038/sj.bjc.6606088 |
_version_ | 1782199242220109824 |
---|---|
author | Valenti, R M Amodio, E Nam, J-M Preiss, L Graubard, B I Romano, N Goedert, J J |
author_facet | Valenti, R M Amodio, E Nam, J-M Preiss, L Graubard, B I Romano, N Goedert, J J |
author_sort | Valenti, R M |
collection | PubMed |
description | BACKGROUND: Immune perturbation likely affects the development of Kaposi sarcoma (KS) among people infected with the KS-associated herpesvirus (KSHV). We tested whether KSHV-seropositive individuals or cases of classic KS (cKS), which typically originates in the leg, had differing delayed-type hypersensitivity (DTH) in the forearm or leg. METHODS: Mantoux DTH with three antigens (Candida, tetanus, PPD) was performed on the forearm and leg of 15 cKS cases, 14 KSHV-positives without KS, and 15 KSHV-negative controls. The diameters of induration responses were compared by group and body site. RESULTS: Leg DTH was greater than forearm DTH among controls (mean difference 5.6 mm, P=0.0004), whereas this was not observed in cKS cases (−2.2 mm, P=0.32) or KSHV-positives (0.5 mm, P=0.56). Leg-minus-forearm DTH difference was greater in controls compared with cKS cases (P=0.004) and KSHV-positives (P=0.002). Leg-plus-forearm DTH was similar in controls (mean 28.2 mm) and cKS cases (24.5 mm, P=0.60), but it was reduced in KSHV-positives (11.8 mm, P=0.02), particularly in the leg (P=0.004) and marginally in the forearm (P=0.07). CONCLUSION: KS cases had weaker DTH only in the leg, whereas both body sites appeared weaker in KSHV-positives without KS. Both systemic and regional immune alterations may influence the development of this malignancy. |
format | Text |
id | pubmed-3049575 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-30495752012-02-01 Delayed-type hypersensitivity in classic Kaposi sarcoma patients and controls Valenti, R M Amodio, E Nam, J-M Preiss, L Graubard, B I Romano, N Goedert, J J Br J Cancer Clinical Study BACKGROUND: Immune perturbation likely affects the development of Kaposi sarcoma (KS) among people infected with the KS-associated herpesvirus (KSHV). We tested whether KSHV-seropositive individuals or cases of classic KS (cKS), which typically originates in the leg, had differing delayed-type hypersensitivity (DTH) in the forearm or leg. METHODS: Mantoux DTH with three antigens (Candida, tetanus, PPD) was performed on the forearm and leg of 15 cKS cases, 14 KSHV-positives without KS, and 15 KSHV-negative controls. The diameters of induration responses were compared by group and body site. RESULTS: Leg DTH was greater than forearm DTH among controls (mean difference 5.6 mm, P=0.0004), whereas this was not observed in cKS cases (−2.2 mm, P=0.32) or KSHV-positives (0.5 mm, P=0.56). Leg-minus-forearm DTH difference was greater in controls compared with cKS cases (P=0.004) and KSHV-positives (P=0.002). Leg-plus-forearm DTH was similar in controls (mean 28.2 mm) and cKS cases (24.5 mm, P=0.60), but it was reduced in KSHV-positives (11.8 mm, P=0.02), particularly in the leg (P=0.004) and marginally in the forearm (P=0.07). CONCLUSION: KS cases had weaker DTH only in the leg, whereas both body sites appeared weaker in KSHV-positives without KS. Both systemic and regional immune alterations may influence the development of this malignancy. Nature Publishing Group 2011-02-01 2011-01-18 /pmc/articles/PMC3049575/ /pubmed/21245864 http://dx.doi.org/10.1038/sj.bjc.6606088 Text en Copyright © 2011 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Clinical Study Valenti, R M Amodio, E Nam, J-M Preiss, L Graubard, B I Romano, N Goedert, J J Delayed-type hypersensitivity in classic Kaposi sarcoma patients and controls |
title | Delayed-type hypersensitivity in classic Kaposi sarcoma patients and controls |
title_full | Delayed-type hypersensitivity in classic Kaposi sarcoma patients and controls |
title_fullStr | Delayed-type hypersensitivity in classic Kaposi sarcoma patients and controls |
title_full_unstemmed | Delayed-type hypersensitivity in classic Kaposi sarcoma patients and controls |
title_short | Delayed-type hypersensitivity in classic Kaposi sarcoma patients and controls |
title_sort | delayed-type hypersensitivity in classic kaposi sarcoma patients and controls |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049575/ https://www.ncbi.nlm.nih.gov/pubmed/21245864 http://dx.doi.org/10.1038/sj.bjc.6606088 |
work_keys_str_mv | AT valentirm delayedtypehypersensitivityinclassickaposisarcomapatientsandcontrols AT amodioe delayedtypehypersensitivityinclassickaposisarcomapatientsandcontrols AT namjm delayedtypehypersensitivityinclassickaposisarcomapatientsandcontrols AT preissl delayedtypehypersensitivityinclassickaposisarcomapatientsandcontrols AT graubardbi delayedtypehypersensitivityinclassickaposisarcomapatientsandcontrols AT romanon delayedtypehypersensitivityinclassickaposisarcomapatientsandcontrols AT goedertjj delayedtypehypersensitivityinclassickaposisarcomapatientsandcontrols |